[Federal Register Volume 64, Number 170 (Thursday, September 2, 1999)]
[Notices]
[Page 48185]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22825]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposal, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel ``Preparation and Distribution of Research Drug 
Products''.
    Date: September 16, 1999.
    Time: 9:00 am to 4:00 pm.
    Agenda: To review and evaluate contract proposals.
    Place: Chevy Chase Holiday Inn, 5520 Wisconsin Ave., Chevy 
Chase, MD 20815.
    Contact Person: Eric Zatman, Contract Review Specialist, Office 
of Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 94547, Bethesda, MD 20892-9547, (301) 435-1438.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: August 26, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-22825 Filed 9-1-99; 8:45 am]
BILLING CODE 4140-01-M